Cargando…

An integrated strategy of biological and physical constraints in biological optimization for cervical carcinoma

BACKGROUND: For cervical carcinoma cases, this study aimed to evaluate the quality of intensity-modulated radiation therapy (IMRT) plans optimized by biological constraints. Furthermore, a new integrated strategy in biological planning module was proposed and verified. METHODS: Twenty patients of ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Ziwei, Tao, Cheng, Zhu, Jian, Chen, Jinhu, Yu, Gang, Qin, Shaohua, Yin, Yong, Li, Dengwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379684/
https://www.ncbi.nlm.nih.gov/pubmed/28376900
http://dx.doi.org/10.1186/s13014-017-0784-1
_version_ 1782519655050510336
author Feng, Ziwei
Tao, Cheng
Zhu, Jian
Chen, Jinhu
Yu, Gang
Qin, Shaohua
Yin, Yong
Li, Dengwang
author_facet Feng, Ziwei
Tao, Cheng
Zhu, Jian
Chen, Jinhu
Yu, Gang
Qin, Shaohua
Yin, Yong
Li, Dengwang
author_sort Feng, Ziwei
collection PubMed
description BACKGROUND: For cervical carcinoma cases, this study aimed to evaluate the quality of intensity-modulated radiation therapy (IMRT) plans optimized by biological constraints. Furthermore, a new integrated strategy in biological planning module was proposed and verified. METHODS: Twenty patients of advanced stage cervical carcinoma were enrolled in this study. For each patient, dose volume optimization (DVO), biological model optimization (BMO) and integrated strategy optimization (ISO) plans were created using same treatment parameters. Different biological models were also used for organ at risk (OAR) in BMO plans, which include the LKB and Poisson models. Next, BMO plans were compared with their corresponding DVO plans, in order to evaluate BMO plan quality. ISO plans were also compared with DVO and BMO plans, in order to verify the performance of the integrated strategy. RESULTS: BMO plans produced slightly inhomogeneity and less coverage of planning target volume (PTV) (V95=96.79, HI = 0.10: p < 0.01). However, the tumor control probability (TCP) value, both from DVO and BMO plans, were comparable. For the OARs, BMO plans produced lower normal tissue complication probability (NTCP) of rectum (NTCP = 0.11) and bladder (NTCP = 0.14) than in the corresponding DVO plans (NTCP = 0.19 and 0.18 for rectum and bladder; p < 0.01 for rectum and p = 0.03 for bladder). V95, D98, CI and HI values that were produced by ISO plans (V95 = 98.31, D98 = 54.18Gy, CI = 0.76, HI = 0.09) were greatly better than BMO plans (V95 = 96.79, D98 = 53.42Gy, CI = 0.71, HI = 0.10) with significant differences. Furthermore, ISO plans produced lower NTCP values of rectum (NTCP = 0.14) and bladder (NTCP = 0.16) than DVO plans (NTCP = 0.19 and 0.18 for rectum and bladder, respectively) with significant differences. CONCLUSIONS: BMO plans produced lower NTCP values of OARs compared to DVO plans for cervical carcinoma cases, and resulted in slightly less target coverage and homogeneity. The integrated strategy, proposed in this study, could improve the coverage, conformity and homogeneity of PTV greater than the BMO plans, as well as reduce the NTCP values of OARs greater than the DVO plans.
format Online
Article
Text
id pubmed-5379684
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53796842017-04-07 An integrated strategy of biological and physical constraints in biological optimization for cervical carcinoma Feng, Ziwei Tao, Cheng Zhu, Jian Chen, Jinhu Yu, Gang Qin, Shaohua Yin, Yong Li, Dengwang Radiat Oncol Research BACKGROUND: For cervical carcinoma cases, this study aimed to evaluate the quality of intensity-modulated radiation therapy (IMRT) plans optimized by biological constraints. Furthermore, a new integrated strategy in biological planning module was proposed and verified. METHODS: Twenty patients of advanced stage cervical carcinoma were enrolled in this study. For each patient, dose volume optimization (DVO), biological model optimization (BMO) and integrated strategy optimization (ISO) plans were created using same treatment parameters. Different biological models were also used for organ at risk (OAR) in BMO plans, which include the LKB and Poisson models. Next, BMO plans were compared with their corresponding DVO plans, in order to evaluate BMO plan quality. ISO plans were also compared with DVO and BMO plans, in order to verify the performance of the integrated strategy. RESULTS: BMO plans produced slightly inhomogeneity and less coverage of planning target volume (PTV) (V95=96.79, HI = 0.10: p < 0.01). However, the tumor control probability (TCP) value, both from DVO and BMO plans, were comparable. For the OARs, BMO plans produced lower normal tissue complication probability (NTCP) of rectum (NTCP = 0.11) and bladder (NTCP = 0.14) than in the corresponding DVO plans (NTCP = 0.19 and 0.18 for rectum and bladder; p < 0.01 for rectum and p = 0.03 for bladder). V95, D98, CI and HI values that were produced by ISO plans (V95 = 98.31, D98 = 54.18Gy, CI = 0.76, HI = 0.09) were greatly better than BMO plans (V95 = 96.79, D98 = 53.42Gy, CI = 0.71, HI = 0.10) with significant differences. Furthermore, ISO plans produced lower NTCP values of rectum (NTCP = 0.14) and bladder (NTCP = 0.16) than DVO plans (NTCP = 0.19 and 0.18 for rectum and bladder, respectively) with significant differences. CONCLUSIONS: BMO plans produced lower NTCP values of OARs compared to DVO plans for cervical carcinoma cases, and resulted in slightly less target coverage and homogeneity. The integrated strategy, proposed in this study, could improve the coverage, conformity and homogeneity of PTV greater than the BMO plans, as well as reduce the NTCP values of OARs greater than the DVO plans. BioMed Central 2017-04-04 /pmc/articles/PMC5379684/ /pubmed/28376900 http://dx.doi.org/10.1186/s13014-017-0784-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Feng, Ziwei
Tao, Cheng
Zhu, Jian
Chen, Jinhu
Yu, Gang
Qin, Shaohua
Yin, Yong
Li, Dengwang
An integrated strategy of biological and physical constraints in biological optimization for cervical carcinoma
title An integrated strategy of biological and physical constraints in biological optimization for cervical carcinoma
title_full An integrated strategy of biological and physical constraints in biological optimization for cervical carcinoma
title_fullStr An integrated strategy of biological and physical constraints in biological optimization for cervical carcinoma
title_full_unstemmed An integrated strategy of biological and physical constraints in biological optimization for cervical carcinoma
title_short An integrated strategy of biological and physical constraints in biological optimization for cervical carcinoma
title_sort integrated strategy of biological and physical constraints in biological optimization for cervical carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379684/
https://www.ncbi.nlm.nih.gov/pubmed/28376900
http://dx.doi.org/10.1186/s13014-017-0784-1
work_keys_str_mv AT fengziwei anintegratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma
AT taocheng anintegratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma
AT zhujian anintegratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma
AT chenjinhu anintegratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma
AT yugang anintegratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma
AT qinshaohua anintegratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma
AT yinyong anintegratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma
AT lidengwang anintegratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma
AT fengziwei integratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma
AT taocheng integratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma
AT zhujian integratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma
AT chenjinhu integratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma
AT yugang integratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma
AT qinshaohua integratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma
AT yinyong integratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma
AT lidengwang integratedstrategyofbiologicalandphysicalconstraintsinbiologicaloptimizationforcervicalcarcinoma